z-logo
Premium
KIAA1549:BRAF fusion gene in pediatric brain tumors of various histogenesis
Author(s) -
Antonelli Manila,
Badiali Manuela,
Moi Loredana,
Buttarelli Francesca R.,
Baldi Caterina,
Massimino Maura,
Sanson Marc,
Giangaspero Felice
Publication year - 2015
Publication title -
pediatric blood and cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.116
H-Index - 105
eISSN - 1545-5017
pISSN - 1545-5009
DOI - 10.1002/pbc.25272
Subject(s) - histogenesis , pilocytic astrocytoma , medicine , pathology , fusion gene , ependymoma , anaplasia , atypical teratoid rhabdoid tumor , anaplastic astrocytoma , grading (engineering) , astrocytoma , pleomorphic xanthoastrocytoma , anaplastic lymphoma kinase , glioma , immunohistochemistry , cancer research , gene , biology , lung cancer , ecology , biochemistry , malignant pleural effusion
The KIAA1549:BRAF fusion gene is considered a driver genetic event in pilocytic astrocytoma. We investigated a series of 69 pediatric brain neoplasms of diverse histogenesis and grade using the RT‐PCR and sequencing. We detected the KIAA1549:BRAF fusion gene in five of 34 non‐PA tumors (14.7%), that is, one glioblastoma, one anaplastic astrocytoma, one anaplastic pleomorphic xanthoastrocytoma, 1 ependymoma, and 1 Atypical Teratoid Rhabdoid Tumor. Our study showed that the K–B, although uncommon, it can be detected in non‐PA tumors of various histogenesis and grading. Pediatr Blood Cancer 2015;62:724–727. © 2014 Wiley Periodicals, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom